Clear Harbor Asset Management, LLC Gilead Sciences, Inc. Transaction History

Clear Harbor Asset Management, LLC

$1.22 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$73.94 - $80.67 $17,006 - $18,554	-230 Reduced 4.6%	4,774 $357,000
Q2 2023 Jul 21, 2023	BUY	$76.01 - $86.7 $22,574 - $25,749	297 Added 6.31%	5,004 $385,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $140,163 - $159,689	1,813 Added 62.65%	4,707 $390,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $180,354 - $258,926	2,894 New	2,894 $0
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $117,662 - $134,070	-2,077 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $465,750 - $585,600	-7,500 Reduced 78.31%	2,077 $131,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $180,850 - $210,000	-2,500 Reduced 20.7%	9,577 $737,000
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $634,567 - $812,789	10,132 Added 520.93%	12,077 $903,000
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $453,153 - $498,454	-7,354 Reduced 79.08%	1,945 $126,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $25,629 - $28,290	410 Added 4.61%	9,299 $589,000
Q2 2019 Jul 22, 2019	SELL	$61.87 - $69.38 $47,639 - $53,422	-770 Reduced 7.97%	8,889 $601,000
Q1 2019 Apr 19, 2019	SELL	$62.53 - $70.05 $34,141 - $38,247	-546 Reduced 5.35%	9,659 $628,000
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $24,821 - $32,390	-410 Reduced 3.86%	10,205 $638,000
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $44,977 - $49,798	-631 Reduced 5.61%	10,615 $728,000
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $8,434 - $9,838	-130 Reduced 1.14%	11,246 $797,000
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $13,184 - $16,072	181 Added 1.62%	11,376 $858,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $36,073 - $42,344	-507 Reduced 4.33%	11,195 $802,000
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $843,831 - $1 Million	11,702	11,702 $948,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.

Account